External Activities

  • Industrial collaborations:Sugen Inc. - Fibroblast growth factor receptor inhibition; Cambridge Antibody Technology (now MedImmune) – Transforming growth factor beta inhibition;Milvella Ltd – Ocular drug delivery;Biologie Servier – Cytotoxicity testing; Anew Optics Inc– IOL development; Calpain Therapeutics – Drug development; Isarna Therapeutics – Drug development; Hoya Surgical Optics - IOL development; Zeiss Meditec - IOL development; SAV IOL - IOL development.
  • Review for: Investigative Ophthalmology and Visual Sciences; Experimental Eye Research; British Journal of Ophthalmology; American Journal of Pathology; Molecular Vision
  • Co-inventor on three international patents. Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors (#95 16458.8); Treatment of fibrotic eye disorders US 61/095547; Treatment of fibrotic eye disorders using an MMP2 inhibitor US 61/095554
  • 1995 & 1996 AER-Chauvin Prize. Awarded for the best abstract by a presenting author, under 35, at the annual JERMOV meeting. In receiving these awards I became the only person ever to win the prize twice, and in successive years.
  • 2008 Elected Fellow of the Royal Society of Medicine
  • 2009 Honorary Chair of Harbin Medical University
  • 2015 National Foundation for Eye Research (NFER) Cataract Research Award
  • 2016 Made a Fellow of the Association for Research in Vision and Ophthalmology (ARVO)
  • Editorial Board Member of IOVS

ID: 19150